NCT05678647View on ClinicalTrials.gov

Sucrosomial Iron and Iron Sulphate to Blood Donors

NAActive, not recruitingINTERVENTIONAL
Enrollment

120

Participants

Timeline

Start Date

January 31, 2023

Primary Completion Date

October 1, 2025

Study Completion Date

January 1, 2026

Conditions
Blood Donation
Interventions
DRUG

Sucrosomial Iron

20 capsules of Sucrosomial Iron 30 mg is given after blood donation

DRUG

Iron Sulfate

20 tablets of oral iron sulphate (Duroferon®) 100 mg is given after blood donation

Trial Locations (1)

75237

Clinical Immunology and Transfusion Medicine, Uppsala University Hospital, Uppsala

All Listed Sponsors
lead

Uppsala University Hospital

OTHER